This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Spravato
  • /
  • A Long-term Safety Study of Esketamine Nasal Spray...
Clinical trial

A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant Depression (SUSTAIN-3)

Read time: 1 mins
Last updated:10th Jan 2021
Status: Active, not recruiting
Identifier: NCT02782104
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest